This is a preprint.
Unlocking the potential of wearable device wear time to enhance postpartum depression screening and detection
- PMID: 39417142
- PMCID: PMC11483018
- DOI: 10.1101/2024.10.07.24315026
Unlocking the potential of wearable device wear time to enhance postpartum depression screening and detection
Update in
-
Unlocking the Potential of Wear Time of a Wearable Device to Enhance Postpartum Depression Screening and Detection: Cross-Sectional Study.JMIR Form Res. 2025 May 23;9:e67585. doi: 10.2196/67585. JMIR Form Res. 2025. PMID: 40409746 Free PMC article.
Abstract
Postpartum depression (PPD) is a mood disorder affecting one in seven women after childbirth that is often under-screened and under-detected. If not diagnosed and treated, PPD is associated with long-term developmental challenges in the child and maternal morbidity. Wearable technologies, such as smartwatches and fitness trackers (e.g., Fitbit), offer continuous and longitudinal digital phenotyping for mood disorder diagnosis and monitoring, with device wear time being an important yet understudied aspect. Using the All of Us Research Program (AoURP) dataset, we assessed the percentage of days women with PPD wore Fitbit devices across pre-pregnancy, pregnancy, postpartum, and PPD periods, as determined by electronic health records. Wear time was compared in women with and without PPD using linear regression models. Results showed a strong trend that women in the PPD cohort wore their Fitbits more those without PPD during the postpartum (PPD: mean=72.9%, SE=13.8%; non-PPD: mean=58.9%, SE=12.2%, P-value=0.09) and PPD time periods (PPD: mean=70.7%, SE=14.5%; non-PPD: mean=55.6%, SE=12.9%, P-value=0.08). We hypothesize this may be attributed to hypervigilance, given the common co-occurrence of anxiety symptoms among women with PPD. Future studies should assess the link between PPD, hypervigilance, and wear time patterns. We envision that device wear patterns with digital biomarkers like sleep and physical activity could enhance early PPD detection using machine learning by alerting clinicians to potential concerns facilitating timely screenings, which may have implications for other mental health disorders.
Conflict of interest statement
Competing interests MAH is a founder of Alamya Health.
Figures






References
-
- Dunn J., Runge R. & Snyder M. Wearables and the medical revolution. Pers. Med. 15, 429–448 (2018). - PubMed
-
- Cox E. Q., Sowa N. A., Meltzer-Brody S. E. & Gaynes B. N. The Perinatal Depression Treatment Cascade: Baby Steps Toward Improving Outcomes. J. Clin. Psychiatry 77, 20901 (2016). - PubMed
-
- Kingston D., Tough S. & Whitfield H. Prenatal and Postpartum Maternal Psychological Distress and Infant Development: A Systematic Review. Child Psychiatry Hum. Dev. 43, 683–714 (2012). - PubMed
Publication types
Grants and funding
- OT2 OD026556/OD/NIH HHS/United States
- U2C OD023196/OD/NIH HHS/United States
- OT2 OD026551/OD/NIH HHS/United States
- U24 OD023121/OD/NIH HHS/United States
- OT2 OD026552/OD/NIH HHS/United States
- OT2 OD026549/OD/NIH HHS/United States
- OT2 OD025337/OD/NIH HHS/United States
- OT2 OD025277/OD/NIH HHS/United States
- OT2 OD026555/OD/NIH HHS/United States
- OT2 OD026550/OD/NIH HHS/United States
- U24 HG011449/HG/NHGRI NIH HHS/United States
- OT2 OD026553/OD/NIH HHS/United States
- OT2 OD023205/OD/NIH HHS/United States
- OT2 OD025276/OD/NIH HHS/United States
- OT2 OD026557/OD/NIH HHS/United States
- OT2 OD026554/OD/NIH HHS/United States
- OT2 OD023206/OD/NIH HHS/United States
- U24 OD023176/OD/NIH HHS/United States
- OT2 OD026548/OD/NIH HHS/United States
- R01 MH131542/MH/NIMH NIH HHS/United States
- OT2 OD025315/OD/NIH HHS/United States
- U24 OD023163/OD/NIH HHS/United States
- RM1 HG010860/HG/NHGRI NIH HHS/United States